HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The Prognostic Significance of Combined Pretreatment Fibrinogen and Neutrophil-Lymphocyte Ratio in Various Cancers: A Systematic Review and Meta-Analysis.

AbstractPURPOSE:
The prognostic value of a new scoring system, termed F-NLR, that combines pretreatment fibrinogen level with neutrophil-lymphocyte ratio has been evaluated in various cancers. However, the results are controversial. The purpose of this study was to comprehensively analyze the prognostic value of F-NLR score in patients with cancers.
METHODS:
An integrated search of relevant studies was conducted by screening the PubMed and Embase databases. Pooled hazard ratios, with 95% confidence intervals (CIs), for overall survival (OS) and disease-free survival (DFS)/progression-free survival (PFS) were calculated to estimate the prognostic significance of F-NLR score in patients with various tumors. A random effects model was used for comprehensive analysis, and subgroup and meta-regression analyses were used to explore sources of heterogeneity.
RESULTS:
Thirteen articles reporting data from of 4747 patients were included in the study. Pooled analysis revealed that high F-NLR score was significantly associated with poor OS (HR = 1.77; 95% CI, 1.51-2.08) and poor DFS/PFS (HR = 1.63; 95% CI, 1.30-2.05). Subgroup and meta-regression analyses did not alter the prognostic role of F-NLR score in OS and DFS/PFS.
CONCLUSIONS:
Increased F-NLR score is significantly associated with poor prognosis in patients with cancers and can serve as an effective prognostic indicator.
AuthorsRongqiang Liu, Shiyang Zheng, Qing Yuan, Peiwen Zhu, Biao Li, Qi Lin, Wenqing Shi, Youlan Min, Qianmin Ge, Yi Shao
JournalDisease markers (Dis Markers) Vol. 2020 Pg. 4565379 ( 2020) ISSN: 1875-8630 [Electronic] United States
PMID33376559 (Publication Type: Journal Article, Meta-Analysis, Systematic Review)
CopyrightCopyright © 2020 Rongqiang Liu et al.
Chemical References
  • Fibrinogen
Topics
  • Disease-Free Survival
  • Fibrinogen (analysis)
  • Humans
  • Leukocyte Count
  • Lymphocytes
  • Neoplasms (blood, diagnosis)
  • Neutrophils
  • Prognosis
  • Progression-Free Survival
  • Proportional Hazards Models

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: